Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin Lesions
Clinical trial NCT03629379 · COMPLETED
Trial details
- NCT number
- NCT03629379
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-22
- Primary completion
- 2021-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.